- Report
- January 2026
- 189 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- May 2026
- 192 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- January 2026
- 184 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- August 2025
- 198 Pages
Global
From €3149EUR$3,545USD£2,743GBP
€3499EUR$3,939USD£3,048GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- July 2024
- 599 Pages
Global
From €4397EUR$4,950USD£3,831GBP
- Report
- April 2023
- 111 Pages
Global
From €4219EUR$4,750USD£3,676GBP
- Report
- July 2024
- 125 Pages
From €3065EUR$3,450USD£2,670GBP
- Report
- July 2024
- 140 Pages
North America
From €3065EUR$3,450USD£2,670GBP
- Report
- October 2023
- 150 Pages
Global
From €4308EUR$4,850USD£3,753GBP
- Report
- August 2024
- 91 Pages
Global
From €3500EUR$4,221USD£3,156GBP
The qPCR Reagent market is a subset of the biotechnology industry, focusing on the production and sale of reagents used in quantitative polymerase chain reaction (qPCR) tests. qPCR is a laboratory technique used to detect and quantify the presence of specific DNA or RNA sequences in a sample. qPCR reagents are used to amplify and detect these sequences, and are essential for the accurate and reliable performance of qPCR tests.
The qPCR Reagent market is highly competitive, with a range of companies offering products for different applications. Companies in the market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, Promega Corporation, Takara Bio, and QIAGEN. Show Less Read more
